HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

TAC 278

prodrug of 5-fluorouracil; RN given refers to cpd with unspecified isomeric designation

Also Known As:

5-Pyrimidinecarboxylic acid, 4-butoxy-5-fluorohexahydro-2,6-dioxo-, ethyl ester, cis-(+-)-; TAC 278, (cis-(+-))-isomer; TAC-278; ethyl t-butoxy-5-fluoro-hexahydro-2,4-dioxopyrimidine-5-carboxylate; 5-Pyrimidinecarboxylic acid, 4-butoxy-5-fluorohexahydro-2,6-dioxo-, ethyl ester

Networked: 3 relevant articles (0 outcomes, 0 trials/studies) for this Bio-Agent, Comments

Bio-Agent Context: Research Results

Heterocyclic Compounds: 37
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 285
    - Pyrimidinones: 13
      - Uracil: 996
        Fluorouracil: 16601
        TAC 278: 3

Related Diseases

1.	Neoplasms (Cancer) 08/01/1982 - "In this paper, UFT, TAC-278, and 5'-DFUR, were particularly investigated from the point of view of pharmacokinetics of those drugs (or 5-FU) in the blood, normal and tumor tissues of patients with gastric cancer. " 01/01/1982 - "On the contrary, 133 mg/m2 of TAC-278, and 200 mg/m2 or 300 mg/m2 of 5'-DFUR (which is activated by thymidine phosphorylase in man) did not produce an effective 5-FU concentration in tumor tissues. " Order ALL the reference details at left...
2.	Stomach Neoplasms (Stomach Cancer) 08/01/1982 - "In this paper, UFT, TAC-278, and 5'-DFUR, were particularly investigated from the point of view of pharmacokinetics of those drugs (or 5-FU) in the blood, normal and tumor tissues of patients with gastric cancer. " Order ALL the reference details at left...
3.	Hydrocephalus (Hydrocephaly) 03/01/1983 - "Seven patients had had irradiation and also had V-P shunt operation for hydrocephalus 5-FU concentration in CSF was extremely high in FD-1 and TAC-278 administration, but not in Tegafur and HCFU administration. " Order ALL the reference details at left...
4.	Brain Neoplasms (Brain Tumor) 03/01/1983 - "Transfer of systemically administered fluorinated pyrimidines (Tegafur, TAC-278, HCFU and FD-1) to cerebrospinal fluid was studied in 7 patients primary brain tumors. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Fluorouracil (Carac)
2.	doxifluridine
3.	Thymidine Phosphorylase
4.	Pyrimidines
5.	Tegafur
6.	1-hexylcarbamoyl-5-fluorouracil (carmofur)
7.	FD 1

blog comments powered by Disqus

TREATMENT OPTIONS
for Neoplasms,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 25767 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Evidence References
Sample PDF Report on Psoriasis >>

Price:

$24.95 USD & Delivery via PDF download
updates for 1 year

Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:

Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
Enable Experts: Quickly identify key researchers and their publications
Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
Research Network: Explore drug and disease relationships visually
Enable Mobile Interface: Access from your cellphone, iPhone or PDA

Price:

$490.00 USD access via web interface
1 year subscription

Request Bulk Institution License Details >>